|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/135 | |
| A61K 31/4985 | |||
| C07C 211/42 | |||
| A61P 25/24 | |||
| A61P 25/28 | |||
| A61P 25/00 |
| (11) | Number of the document | 2455075 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12152928.3 |
| Date of filing the European patent application | 2006-07-06 | |
| (97) | Date of publication of the European application | 2012-05-23 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 697013 P | 2005-07-06 | US |
| (72) |
Koenig, Stephen G., US
Bakale, Roger P., US
Singh, Surendra P., US
Scott, Wilkinson, US
Su, Xiping, US
Han, Zhengxu, US
|
| (73) |
Sunovion Pharmaceuticals Inc.,
84 Waterford Drive, Marlborough, MA 01752,
US
|
| (54) | Process for Preparation of trans 4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine |
| Process for Preparation of trans 4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine |